arrow
A

Andrea Zanichelli

IRCCS Policlinico San Donato
H指数:42
被引数:6,732

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Sustained Effectiveness of Lanadelumab in Preventing Hereditary Angioedema Attacks: The ENABLE Study

兰扎鲁玛在预防遗传性血管性水肿发作中的持续有效性:ENABLE研究

2026-08-060
OA
The International/Canadian hereditary angioedema guideline

国际/加拿大遗传性血管性水肿指南

2026-01-280
OAAI
Sebetralstat for On-Demand Treatment of Mucosal Hereditary Angioedema Attacks in KONFIDENT-S

Sebetralstat用于KONFIDENT-S中黏膜遗传性血管性水肿发作的按需治疗

2025-11-010
OAAI
Long-term Safety and Effectiveness of Sebetralstat: Interim Analysis of KONFIDENT-S Open-label Extension

Sebetralstat的长期安全性与有效性:KONFIDENT-S开放标签扩展研究的期中分析

2025-08-290
OAAI
Lanadelumab’s impact on hereditary angioedema control and quality of life across disease activity subgroups: real-world evidence

Lanadelumab对遗传性血管性水肿控制及生活质量的影响:按疾病活动度亚组分析的真实世界证据

2025-08-050
OAAI
The Impact of COVID-19 on Patients With Bradykinin-Mediated Angioedema in the ITACA Cohort

COVID-19对ITACA队列中缓激肽介导性血管性水肿患者的影响

2025-05-090
PRE
Assessment of potential drug-drug interactions in patients with hereditary angioedema from the ITACA cohort: simulations from a real-life dataset considering danazol versus berotralstat

对遗传性血管性水肿患者中潜在药物-药物相互作用的评估:来自ITACA队列的研究,基于真实世界数据集的模拟,比较达那唑与贝洛曲stat的差异

2025-04-250
OA
Rare connective tissue diseases in patients with C1-inhibitor deficiency hereditary angioedema: first evidence on prevalence and distribution from a large Italian cohort study
2024-10-180
OAAI
EXcellenT (exercise in extended oncogene addicted lung cancer in active treatment) trial: Preliminary results on impact of physical activity (PA) on emotional, metabolic and immune status

EXcellenT(针对活跃治疗中扩展性致癌基因依赖性肺癌的运动试验)研究:关于身体活动(PA)对情绪、代谢和免疫状态影响的初步结果

2024-09-010
PRE